An Efficacy and Safety Study of JYP0061 Tablets in Adult Patients With Moderate-to-Severe Atopic Dermatitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Clinical Trial
The goal of this clinical trial is to evaluate the efficacy and safety of JYP0061 in adult patients with moderate-to-severe atopic dermatitis. The main questions it aims to answer are:
The efficacy of JYP0061 in treating adult patients with moderate-to-severe atopic dermatitis.
The safety profile of JYP0061 when administered to adult patients with moderate-to-severe atopic dermatitis.
Participants will:
Be treated with either a low-dose or high-dose of JYP0061.
Undergo efficacy and safety evaluations as stipulated in the trial protocol.
Safety, Tolerability and Pharmacokinetic Characteristics of JYP0061 in Healthy Adult Subjects After Single and Multiple Doses: a Single-center, Randomized, Double-blind, Placebo-controlled, Phase I Trial
The goal of this clinical trial is to evaluate the safety, tolerability and pharmacokinetic characteristics of JYP0061 in healthy adult subjects. The main questions it aims to answer are: safety and tolerability of JYP0061 in healthy subjects, the pharmacokinetic characteristics after single and multiple doses and the effect of food on the pharmacokinetic characteristics. Participants will be treated with JYP0061 orally and safety and pharmacokinetic evaluations will be conducted according to the protocol.
一项采用单中心、随机、双盲、安慰剂对照、剂量递增试验设计,评估健康成人志愿者单次和多次口服JYP0061的安全性、耐受性及药代动力学及药效学特征的临床试验。
本研究的主要目的是评估健康成人单次和多次服用JYP0061片后的安全性和耐受性。评价的主要终点指标为在规定的评估时间内不良事件、严重不良事件的发生率。
100 项与 JYP-0061 相关的专利(医药)